Thomas C. Freyman, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 30,644 shares at $39.10 ($1.2M) on 2014-03-03, disclosed to the SEC on 2014-03-04.
Scheduled sale ($1.2M) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.79 | 27,660 | $1.1M | 90.4% |
| 2 | $39.10 | 2,984 | $117K | 9.6% |
| Total | $39.72 avg | 30,644 | $1.2M | 100% |
| Filing → |
| TEN | BUY | 2018-08-10 | $222K | — | Filing → |
| TEN | BUY | 2013-05-03 | $57K | — | Filing → |
| ABT | SELL | 2011-08-09 | $974K | — | Filing → |